Cargando…
Concurrent mutations in RNA-dependent RNA polymerase and spike protein emerged as the epidemiologically most successful SARS-CoV-2 variant
The D614G mutation in the Spike protein of the SARS-CoV-2 has effectively replaced the early pandemic-causing variant. Using pseudotyped lentivectors, we confirmed that the aspartate replacement by glycine in position 614 is markedly more infectious. Molecular modelling suggests that the G614 mutati...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8249556/ https://www.ncbi.nlm.nih.gov/pubmed/34210996 http://dx.doi.org/10.1038/s41598-021-91662-w |
_version_ | 1783716920889966592 |
---|---|
author | Ilmjärv, Sten Abdul, Fabien Acosta-Gutiérrez, Silvia Estarellas, Carolina Galdadas, Ioannis Casimir, Marina Alessandrini, Marco Gervasio, Francesco Luigi Krause, Karl-Heinz |
author_facet | Ilmjärv, Sten Abdul, Fabien Acosta-Gutiérrez, Silvia Estarellas, Carolina Galdadas, Ioannis Casimir, Marina Alessandrini, Marco Gervasio, Francesco Luigi Krause, Karl-Heinz |
author_sort | Ilmjärv, Sten |
collection | PubMed |
description | The D614G mutation in the Spike protein of the SARS-CoV-2 has effectively replaced the early pandemic-causing variant. Using pseudotyped lentivectors, we confirmed that the aspartate replacement by glycine in position 614 is markedly more infectious. Molecular modelling suggests that the G614 mutation facilitates transition towards an open state of the Spike protein. To explain the epidemiological success of D614G, we analysed the evolution of 27,086 high-quality SARS-CoV-2 genome sequences from GISAID. We observed striking coevolution of D614G with the P323L mutation in the viral polymerase. Importantly, the exclusive presence of G614 or L323 did not become epidemiologically relevant. In contrast, the combination of the two mutations gave rise to a viral G/L variant that has all but replaced the initial D/P variant. Our results suggest that the P323L mutation, located in the interface domain of the RNA-dependent RNA polymerase, is a necessary alteration that led to the epidemiological success of the present variant of SARS-CoV-2. However, we did not observe a significant correlation between reported COVID-19 mortality in different countries and the prevalence of the Wuhan versus G/L variant. Nevertheless, when comparing the speed of emergence and the ultimate predominance in individual countries, it is clear that the G/L variant displays major epidemiological supremacy over the original variant. |
format | Online Article Text |
id | pubmed-8249556 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-82495562021-07-06 Concurrent mutations in RNA-dependent RNA polymerase and spike protein emerged as the epidemiologically most successful SARS-CoV-2 variant Ilmjärv, Sten Abdul, Fabien Acosta-Gutiérrez, Silvia Estarellas, Carolina Galdadas, Ioannis Casimir, Marina Alessandrini, Marco Gervasio, Francesco Luigi Krause, Karl-Heinz Sci Rep Article The D614G mutation in the Spike protein of the SARS-CoV-2 has effectively replaced the early pandemic-causing variant. Using pseudotyped lentivectors, we confirmed that the aspartate replacement by glycine in position 614 is markedly more infectious. Molecular modelling suggests that the G614 mutation facilitates transition towards an open state of the Spike protein. To explain the epidemiological success of D614G, we analysed the evolution of 27,086 high-quality SARS-CoV-2 genome sequences from GISAID. We observed striking coevolution of D614G with the P323L mutation in the viral polymerase. Importantly, the exclusive presence of G614 or L323 did not become epidemiologically relevant. In contrast, the combination of the two mutations gave rise to a viral G/L variant that has all but replaced the initial D/P variant. Our results suggest that the P323L mutation, located in the interface domain of the RNA-dependent RNA polymerase, is a necessary alteration that led to the epidemiological success of the present variant of SARS-CoV-2. However, we did not observe a significant correlation between reported COVID-19 mortality in different countries and the prevalence of the Wuhan versus G/L variant. Nevertheless, when comparing the speed of emergence and the ultimate predominance in individual countries, it is clear that the G/L variant displays major epidemiological supremacy over the original variant. Nature Publishing Group UK 2021-07-01 /pmc/articles/PMC8249556/ /pubmed/34210996 http://dx.doi.org/10.1038/s41598-021-91662-w Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Ilmjärv, Sten Abdul, Fabien Acosta-Gutiérrez, Silvia Estarellas, Carolina Galdadas, Ioannis Casimir, Marina Alessandrini, Marco Gervasio, Francesco Luigi Krause, Karl-Heinz Concurrent mutations in RNA-dependent RNA polymerase and spike protein emerged as the epidemiologically most successful SARS-CoV-2 variant |
title | Concurrent mutations in RNA-dependent RNA polymerase and spike protein emerged as the epidemiologically most successful SARS-CoV-2 variant |
title_full | Concurrent mutations in RNA-dependent RNA polymerase and spike protein emerged as the epidemiologically most successful SARS-CoV-2 variant |
title_fullStr | Concurrent mutations in RNA-dependent RNA polymerase and spike protein emerged as the epidemiologically most successful SARS-CoV-2 variant |
title_full_unstemmed | Concurrent mutations in RNA-dependent RNA polymerase and spike protein emerged as the epidemiologically most successful SARS-CoV-2 variant |
title_short | Concurrent mutations in RNA-dependent RNA polymerase and spike protein emerged as the epidemiologically most successful SARS-CoV-2 variant |
title_sort | concurrent mutations in rna-dependent rna polymerase and spike protein emerged as the epidemiologically most successful sars-cov-2 variant |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8249556/ https://www.ncbi.nlm.nih.gov/pubmed/34210996 http://dx.doi.org/10.1038/s41598-021-91662-w |
work_keys_str_mv | AT ilmjarvsten concurrentmutationsinrnadependentrnapolymeraseandspikeproteinemergedastheepidemiologicallymostsuccessfulsarscov2variant AT abdulfabien concurrentmutationsinrnadependentrnapolymeraseandspikeproteinemergedastheepidemiologicallymostsuccessfulsarscov2variant AT acostagutierrezsilvia concurrentmutationsinrnadependentrnapolymeraseandspikeproteinemergedastheepidemiologicallymostsuccessfulsarscov2variant AT estarellascarolina concurrentmutationsinrnadependentrnapolymeraseandspikeproteinemergedastheepidemiologicallymostsuccessfulsarscov2variant AT galdadasioannis concurrentmutationsinrnadependentrnapolymeraseandspikeproteinemergedastheepidemiologicallymostsuccessfulsarscov2variant AT casimirmarina concurrentmutationsinrnadependentrnapolymeraseandspikeproteinemergedastheepidemiologicallymostsuccessfulsarscov2variant AT alessandrinimarco concurrentmutationsinrnadependentrnapolymeraseandspikeproteinemergedastheepidemiologicallymostsuccessfulsarscov2variant AT gervasiofrancescoluigi concurrentmutationsinrnadependentrnapolymeraseandspikeproteinemergedastheepidemiologicallymostsuccessfulsarscov2variant AT krausekarlheinz concurrentmutationsinrnadependentrnapolymeraseandspikeproteinemergedastheepidemiologicallymostsuccessfulsarscov2variant |